Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with type 2 diabetes and obesity
The 3-mg dosage is for initiation of treatment only to reduce GI intolerance and is not effective for glycemic control
Race and ethnicity: No clinically relevant effect on pharmacokinetics
Over a trial period of 31 days, participants treated with Y14 peptide experienced a weight reduction of 2.9 to 3.6 kilograms, with a 38% to 55% reduction in food intake compared to the placebo group
US$ 22.83
US$ 26.00
US$ 28.47
US$ 27.05
US$ 21.18
US$ 21.83
US$ 20.74
US$ 24.53
US$ 23.43
US$ 29.93
US$ 21.89
